Top Page
Kindly MD
(NASDAQ:NAKA)
Kindly MD (NAKA) vs. SPDR S&P 500 ETF (SPY)
Kindly MD Business Overview & Revenue Model
Kindly MD Financial Statement Overview
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.24M | 2.72M | 3.77M | 3.79M | 2.50M |
| Gross Profit | 2.21M | 2.64M | -264.17K | -595.29K | 914.92K |
| EBITDA | -5.23M | -3.00M | -1.36M | -2.42M | 124.74K |
| Net Income | -5.47M | -3.62M | -1.62M | -2.54M | 149.34K |
Balance Sheet | |||||
| Total Assets | 9.89M | 3.68M | 1.10M | 947.00K | 447.64K |
| Cash, Cash Equivalents and Short-Term Investments | 6.02M | 2.27M | 525.50K | 186.92K | 94.69K |
| Total Debt | 559.02K | 783.68K | 636.38K | 391.13K | 109.81K |
| Total Liabilities | 923.39K | 1.11M | 1.21M | 565.98K | 174.56K |
| Stockholders Equity | 8.97M | 2.57M | -108.41K | 381.01K | 273.09K |
Cash Flow | |||||
| Free Cash Flow | -5.98M | -3.09M | -463.91K | -457.77K | 57.84K |
| Operating Cash Flow | -5.59M | -3.07M | -449.49K | -140.38K | 121.44K |
| Investing Cash Flow | -3.09M | -401.63K | -14.42K | -317.39K | -63.60K |
| Financing Cash Flow | 8.82M | 5.22M | 802.49K | 550.00K | -45.34K |
Kindly MD Technical Analysis
Kindly MD Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
67 Neutral | $5.78B | 53.47 | 4.25% | ― | 17.23% | ― | |
63 Neutral | $16.36B | 71.77 | 4.71% | ― | 22.86% | ― | |
63 Neutral | $401.15M | 6.28 | 15.04% | ― | 2.83% | ― | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
50 Neutral | $6.26B | 144.94 | ― | ― | -40.08% | ― | |
41 Neutral | ― | -0.91 | -81.92% | ― | -27.67% | -110.06% |
Kindly MD Corporate Events
On October 7, 2025, KindlyMD announced a strategic partnership with fintech company Antalpha to establish a $250 million convertible debt facility. This collaboration aims to create innovative financing tools for the Bitcoin market, enhancing Bitcoin’s adoption among public companies. The partnership includes a non-binding agreement for Nakamoto, KindlyMD’s subsidiary, to issue secured convertible notes to Antalpha, providing long-term financing with less dilution risk to stockholders. The proceeds will also replace a prior $203 million Bitcoin-secured credit, with the interim financing provided by Antalpha. This initiative marks the first step in a broader effort to develop tailored financial solutions for Bitcoin treasury companies.
The most recent analyst rating on (NAKA) stock is a Sell with a $1.50 price target. To see the full list of analyst forecasts on Kindly MD stock, see the NAKA Stock Forecast page.
On September 30, 2025, KindlyMD repaid its $203 million Secured Convertible Debenture to Yorkville Advisors, effectively terminating the related agreements. This move was part of a strategic shift, as the company secured a $200 million credit facility from Two Prime, aimed at enhancing its balance sheet and aligning its capital structure with shareholder interests. The financing allows KindlyMD to pursue long-term growth while preserving its Bitcoin holdings, thus strengthening its position in the healthcare and Bitcoin treasury sectors.
The most recent analyst rating on (NAKA) stock is a Sell with a $1.50 price target. To see the full list of analyst forecasts on Kindly MD stock, see the NAKA Stock Forecast page.
Kindly MD, Inc. announced that its 2025 Annual Meeting of Stockholders will be held virtually on December 17, 2025, with October 23, 2025, set as the record date for stockholders entitled to vote. The meeting date has been moved forward by over 30 days from the previous year’s meeting, prompting a new deadline of October 6, 2025, for stockholder proposals and director nominations to be considered for inclusion in the proxy materials.
The most recent analyst rating on (NAKA) stock is a Sell with a $1.50 price target. To see the full list of analyst forecasts on Kindly MD stock, see the NAKA Stock Forecast page.
On September 15, 2025, Kindly MD, Inc. announced its intention to redeem its Secured Convertible Debenture issued on August 15, 2025. The redemption, scheduled for September 29, 2025, will involve a cash payment of 100% of the outstanding principal plus a 1.5% premium, totaling $203,000,000 if not converted by the holder. This move indicates a strategic financial decision by the company, potentially impacting its financial structure and stakeholder relations.
The most recent analyst rating on (NAKA) stock is a Hold with a $2.50 price target. To see the full list of analyst forecasts on Kindly MD stock, see the NAKA Stock Forecast page.
On September 15, 2025, Kindly MD, Inc. informed shareholders about filing a Form S-3 on September 12, 2025, which may lead to increased share price volatility. The company emphasized its commitment to its long-term vision and highlighted its strategy to build a Bitcoin-denominated treasury and invest in Bitcoin-focused companies. Kindly MD has achieved significant milestones, including raising $742 million, establishing a 5,700+ BTC treasury, and launching a $5 billion ATM program. The company aims to capitalize on Bitcoin’s mainstream acceptance and expand access to Bitcoin through publicly-traded Bitcoin treasury companies, ultimately enhancing liquidity and shareholder value.
The most recent analyst rating on (NAKA) stock is a Hold with a $2.50 price target. To see the full list of analyst forecasts on Kindly MD stock, see the NAKA Stock Forecast page.
On September 9, 2025, KindlyMD’s subsidiary, Nakamoto Holdings, committed to investing up to $30 million in Metaplanet Inc.’s international equity financing. This marks Nakamoto’s largest single investment and its first in an Asian public company with a Bitcoin treasury strategy. The investment aims to support Metaplanet’s efforts to accelerate Bitcoin accumulation and expand its net asset value, with the funding expected on September 16, 2025. The transaction underscores KindlyMD’s strategic focus on integrating Bitcoin into global capital markets, enhancing its positioning in the Bitcoin and healthcare industries.
The most recent analyst rating on (NAKA) stock is a Hold with a $8.00 price target. To see the full list of analyst forecasts on Kindly MD stock, see the NAKA Stock Forecast page.
On September 4, 2025, Kindly MD‘s subsidiary, Nakamoto Holdings, made a minority investment in Treasury B.V., a Bitcoin treasury company in the Netherlands, marking Nakamoto’s first foreign investment. This move is part of Treasury’s plan to reverse list on Euronext Amsterdam and expand Bitcoin access in European markets. The transaction includes a lock-up agreement and observer rights for Nakamoto, and Treasury plans to establish a strategic advisory board with Kindly MD’s CEO, David Bailey, as a member.
The most recent analyst rating on (NAKA) stock is a Sell with a $3.00 price target. To see the full list of analyst forecasts on Kindly MD stock, see the NAKA Stock Forecast page.
On August 26, 2025, Kindly MD, Inc. entered into a Sales Agreement with several financial agents, including TD Securities and Cantor Fitzgerald, to offer and sell up to $5 billion of its common stock through an at-the-market offering. This strategic move allows Kindly MD to raise capital flexibly, potentially strengthening its financial position and market presence, while providing agents with a commission of up to 2% on the sales.
The most recent analyst rating on (NAKA) stock is a Hold with a $10.00 price target. To see the full list of analyst forecasts on Kindly MD stock, see the NAKA Stock Forecast page.
On August 14, 2025, KindlyMD completed its merger with Nakamoto Holdings, making Nakamoto a wholly-owned subsidiary and establishing a Bitcoin treasury vehicle. The merger, along with PIPE Financing that raised $540 million, aims to advance Bitcoin adoption in global capital markets and enhance KindlyMD’s strategic positioning. The company announced a new leadership team, including David Bailey as CEO, and plans to focus on acquiring Bitcoin at scale, leveraging Nakamoto’s vision for integrating Bitcoin into capital markets. The merger also resulted in changes to the board of directors and executive roles, with new appointments to drive the company’s growth and Bitcoin strategy.